Area of research
Hepatology · Epidemiology
Research interest
Research interests include Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, and COVID-19 Clinical Research Studies.
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection.
Sex-related differences in patients with chronic hepatitis C infection treated with direct-acting antiviral drugs.
Management of SARS-CoV-2 Infection-Clinical Practice Guidelines of the Polish Association of Epidemiologists and Infectiologists, for 2025.
Clinical characteristics of patients with primary biliary cholangitis treated with ursodeoxycholic acid.
Herpes zoster prevention in multiple sclerosis and neuromyelitis optica spectrum disorders.
Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver disease.
Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes.
Trends and Socio-Demographic Patterns of Hepatitis B Virus Hospitalisations in Poland: A 12-Year Nationwide Analysis.
Guidelines of the Polish Society of Gynecologists and Obstetricians on the management of girls and women subjected to sexual violence.
The Impact of COVID-19 and the Practical Importance of Vaccinations and Nirmatrelvir/Ritonavir for Patients with Cardiovascular Disease.
Rationale and design of the administrative data and electronic medical records-based registry: The Cardiology Scientific Network of the Medical University of Silesia (CardioSilesia).
Humoral anti-SARS-CoV-2 response in patients with different long COVID phenotypes
Treatment of the most difficult-to-cure hepatitis C virus-infected population with sofosbuvir / velpatasvir.
Direct-acting antivirals in women of reproductive age infected with hepatitis C virus.
Kinetics and Value of Hepatitis B Core-Related Antigen in Patients with Chronic Hepatitis B Virus Infection during Antiviral Treatment.
Association between Liver Damage and Disease Progression Markers with Mortality Risk and Mechanical Ventilation in Hospitalized COVID-19 Patients: A Nationwide Retrospective SARSTer Study.
Prevalence of HDV infections in Poland based on the experience of a single center in Silesia and literature research.
Effectiveness and safety of direct-acting antivirals in the therapy of HCV-infected elderly people.
Sustained Virological Response After Early Discontinuation of Hepatitis C Treatment.
Patient with actinomycosis of the cervicofacial and abdominal area, case report.
Neutrophil Gelatinase-Associated Lipocalin as a Biomarker in Post-Acute COVID-19 Syndrome.
The Real-World Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C in Patients Active Malignancies.
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study.
Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database.
Overview of autoantibodies in COVID-19 convalescents.
Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2023.
Differences between the course of SARS-CoV-2 infections in the periods of the Delta and Omicron variant dominance in Poland.
Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review.
Change in the Clinical Picture of Hospitalized Patients with COVID-19 between the Early and Late Period of Dominance of the Omicron SARS-CoV-2 Variant.
Gene-Editing and RNA Interference in Treating Hepatitis B: A Review.